Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

PopSci CHW4CervixHealth

Thomas Jefferson University · with Roche Pharma AG · NCT07336134

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 25–65 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
120
US sites recruiting
1
Study start
October 22, 2025
Record last updated
August 11, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients.

Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to promote HPV self-collection uptake among screening-eligible and under-screened ethnic minority women in the community.

Being studied: Evalyn® Brush; Copan Floqswab; CHW4CervicalHealth

Conditions: Cervical Cancer; Hpv; Human Papilloma Virus; HPV Infection

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Phase I

  • Women aged 25-65 years
  • Scheduled for a Pap smear test appointment at Jefferson OBGYN Center City location
  • Willing and able to provide informed consent for participation in the study
  • Agree to perform an HPV self-collection collection procedure during the same visit
  • Have not undergone a hysterectomy (intact cervix required)

Phase II

This intervention targets under-screened minority individuals who must meet all the following inclusion criteria to be eligible to participate in the study:

  • Women aged 25-65 years
  • Who has not had a Pap smear in the past three to five years based on age of prior screening and type of screening. If under the age of 30, in the past 3 years and if over the age of 30, in the past 5 years. Participant will self-report normal pap smear and date.
  • Self-identify as Hispanic, Black/African or Black Caribbean, Chinese, Korean, or Vietnamese
  • Competent to give consent and provide signed and dated informed consent form in their preferred language.

Exclusion Criteria

Phase I

  • Current pregnancy (self-reported or confirmed)
  • Previous participation in an HPV self-collection study within the past 12 months
  • Presence of visible vaginal or cervical infection or symptoms suggestive of a current genital tract infection
  • Inability to comply with study procedures or follow instructions (e.g., due to language barriers or cognitive impairments)

Phase II

An individual who meets any of the following criteria will be excluded from participation in this study:

  • Have a history of hysterectomy, cervical cancer
  • Self-report participation in a cervical cancer screening or other prevention study
  • Pregnant (self-reported)
  • Inability to provide informed consent

Recruiting US locations

  • Thomas Jefferson University

    Philadelphia, PA 19107

    Site contact: Sandra Dayaratna, MD, MBA · 215-600-9151 · ONCTrialNow@jefferson.edu

Study contacts (from the official record)

  • Site Public Contact · 215-600-9151 · ONCTrialNow@jefferson.edu
PopSci CHW4CervixHealth (NCT07336134) | Bored Studies